Skip to content

OIS@SECO

MARCH 4, 2020 | ATLANTA, GA

The “Ophthalmic” Innovation Summit was introduced to facilitate meaningful interactions between ODs, MDs and Industry leaders to accelerate the adoption of innovative non-surgical therapies to address prevalent eye diseases and disorders.

OIS ISRAEL 2020

MARCH 18, 2020 | TEL AVIV, ISRAEL

Ophthalmology Innovation Summit is proud to announce our first international meeting in the beautiful city of Tel Aviv, Israel.

 

OIS ANTERIOR 2020

MAY 14, 2020 | CAMBRIDGE, MA

This Ophthalmology Innovation Summit unites over 600 Corporate, Clinical and Capital leaders to collaborate on the development and commercialization of innovative therapies for the anterior segment.

OIS RETINA 2020

JULY 23, 2020 | SEATTLE, WA

This Ophthalmology Innovation Summit unites 300 Corporate, Clinical and Capital leaders to collaborate on the development and commercialization of innovative therapies for the posterior segment.

12TH ANNUAL OIS 2020

NOVEMBER 12, 2020 | LAS VEGAS, NV

The Ophthalmology Innovation Summit began in 2009 and now unites over 1,200 Corporate, Clinical and Capital leaders to collaborate on the development and commercialization of innovative drugs, devices and diagnostics to address unmet vision disorders.

The Ophthalmology Innovation Summits facilitate meaningful interactions and the exchange of information between clinical, capital and corporate leaders to accelerate the development and commercialization of novel therapies to address unmet needs.

LATEST NEWS

Keeping an "Eye on Innovation" Through News & Analysis

Lucentis and Eylea patent expirations in the micro-crystal ball

Lucentis and Eylea patent expirations in the micro-crystal ball

Over the past 10 years, the Dow Jones Industrial Average has seen a 10-year climb with small calendar-year dips seen in 2015 (-2.23%) and 2018 ...
OIS Index Posts a Strong Finish to 2019

OIS Index Posts a Strong Finish to 2019

The OIS Index of ophthalmic stocks made a strong comeback in Q4-2019, following a rough Q3. The index gained 16.2% in Q4, slightly underperforming the ...
Innovations a Highlight at Dry Eye Breakout Session

Innovations a Highlight at Dry Eye Breakout Session

The dry eye disease (DED) market is expected to have an annual compound growth rate of 4.5% between 2017 and 2025, which should help it ...
BioGenware’s Speculet Seeks to Improve the Patient Experience

BioGenware’s Speculet Seeks to Improve the Patient Experience

For those undergoing intravitreal injections (and there are about 22 million of these performed yearly worldwide), a common complaint is that the speculum is uncomfortable, ...
We’ve Got Your BAK

We’ve Got Your BAK

Imagine a world where you could use as much preservative as you needed in a prescription eye drop without ever having to worry it would ...
OIS Index Outperforms

OIS Index Outperforms

The OIS Index of ophthalmic stocks gained 5.4% in November, following a similar 5.2% gain in October. The index outperformed medical device stocks (+4.3%) and ...

STAY UP TO DATE WITH OIS

Get the Latest News, Podcasts and Videos.

Scroll To Top